HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Peter Orendáš Selected Research

Peter Orendáš Research Topics

Disease

6Neoplasms (Cancer)
11/2014 - 12/2011
4Breast Neoplasms (Breast Cancer)
11/2014 - 03/2012
3Carcinoma (Carcinomatosis)
12/2014 - 03/2012
2Body Weight (Weight, Body)
07/2013 - 03/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
08/2014

Drug/Important Bio-Agent (IBA)

3Caspase 3 (Caspase-3)IBA
12/2014 - 07/2013
3MelatoninIBA
12/2014 - 03/2012
2Caspase 7IBA
12/2014 - 10/2014
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2014 - 07/2013
2resveratrolIBA
11/2014 - 03/2012
2pioglitazone (Actos)FDA Link
08/2014 - 12/2011
2ThiazolidinedionesIBA
08/2014 - 12/2011
1Pravastatin (Pravachol)FDA LinkGeneric
12/2014
1CaspasesIBA
12/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2014
1Messenger RNA (mRNA)IBA
11/2014
1Indicators and Reagents (Reagents)IBA
11/2014
1celecoxib (Celebrex)FDA Link
11/2014
1Growth Differentiation Factor 15IBA
11/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014
1pitavastatin (itavastatin)FDA Link
10/2014
1PrebioticsIBA
09/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2014
1oligofructoseIBA
09/2014
1InulinFDA Link
09/2014
1fluvastatinFDA Link
07/2013
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
03/2012